Mediators of First- Versus Second-generation Antipsychotic-related Mortality in Older Adults
- PMID: 26035686
- PMCID: PMC4720122
- DOI: 10.1097/EDE.0000000000000321
Mediators of First- Versus Second-generation Antipsychotic-related Mortality in Older Adults
Abstract
Background: Observational studies of older adults showed higher mortality for first-generation antipsychotics than their second- generation counterparts, which led to US Food and Drug Administration warnings, but the actual mechanisms involved remain unclear.
Methods: A cohort of 9,060 initiators of first-generation antipsychotics and 17,137 of second-generation antipsychotics enrolled in New Jersey and Pennsylvania Medicare were followed for 180 days. Medical events were assessed using diagnostic and procedure codes on inpatient billing claims. For the individual and joint set of medical events (mediators), we estimated the total, direct, and indirect effects of antipsychotic type (first versus second generation) on mortality on the risk ratio scale and the proportion mediated on the risk difference scale, obtaining 95% confidence intervals through bootstrapping. We performed bias analyses for false-negative mediator misclassification in claims data, with sensitivity ranging from 0.25 to 0.75.
Results: There were 3,199 deaths (outcomes), 862 cardiovascular events, 675 infectious events, and 491 hip fractures (potential mediators). Mortality was higher for first- than second-generation antipsychotic initiators (adjusted risk ratio: 1.14; 95% confidence interval: 1.06, 1.22). In naïve analyses, that ignored potential misclassification, less than 4% of this difference was explained by any particular medical event. In bias analyses, the proportion mediated ranged from 6% to 16% for stroke, 3% to 9% for ventricular arrhythmia, 3% to 11% for myocardial infarction, 0% venous thromboembolism, 3% to 9% for pneumonia, 0% to 1% for other bacterial infection, and 1% to 3% for hip fracture.
Conclusions: Acute cardiovascular events and pneumonia may explain part of the mortality difference between first- and second-generation antipsychotic initiators in this analysis.
Figures
Similar articles
-
Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis.PLoS One. 2014 Aug 20;9(8):e105376. doi: 10.1371/journal.pone.0105376. eCollection 2014. PLoS One. 2014. PMID: 25140533 Free PMC article. Review.
-
The explanatory role of stroke as a mediator of the mortality risk difference between older adults who initiate first- versus second-generation antipsychotic drugs.Am J Epidemiol. 2014 Oct 15;180(8):847-52. doi: 10.1093/aje/kwu210. Epub 2014 Sep 18. Am J Epidemiol. 2014. PMID: 25234432 Free PMC article.
-
Risk of cerebrovascular adverse events in older adults using antipsychotic agents: a propensity-matched retrospective cohort study.J Clin Psychiatry. 2010 Jun;71(6):689-98. doi: 10.4088/JCP.09m05817yel. J Clin Psychiatry. 2010. PMID: 20573328
-
Antipsychotic drug use and pneumonia: Systematic review and meta-analysis.J Psychopharmacol. 2018 Nov;32(11):1167-1181. doi: 10.1177/0269881118795333. Epub 2018 Oct 18. J Psychopharmacol. 2018. PMID: 30334664
-
Choice of observational study design impacts on measurement of antipsychotic risks in the elderly: a systematic review.BMC Med Res Methodol. 2012 Jun 8;12:72. doi: 10.1186/1471-2288-12-72. BMC Med Res Methodol. 2012. PMID: 22682666 Free PMC article. Review.
Cited by 8 articles
-
Psychotropic Drug-Associated Pneumonia in Older Adults.Drugs Aging. 2020 Apr;37(4):241-261. doi: 10.1007/s40266-020-00754-1. Drugs Aging. 2020. PMID: 32107741 Free PMC article. Review.
-
Mortality Risk Associated with Haloperidol Use Compared with Other Antipsychotics: An 11-Year Population-Based Propensity-Score-Matched Cohort Study.CNS Drugs. 2020 Feb;34(2):197-206. doi: 10.1007/s40263-019-00693-5. CNS Drugs. 2020. PMID: 31916101
-
Antipsychotics and the Risk of Mortality or Cardiopulmonary Arrest in Hospitalized Adults.J Am Geriatr Soc. 2020 Mar;68(3):544-550. doi: 10.1111/jgs.16246. Epub 2019 Nov 19. J Am Geriatr Soc. 2020. PMID: 31743435
-
Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses.PLoS One. 2017 Oct 27;12(10):e0187034. doi: 10.1371/journal.pone.0187034. eCollection 2017. PLoS One. 2017. PMID: 29077727 Free PMC article. Review.
-
Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review.Ther Clin Risk Manag. 2017 Jun 29;13:757-777. doi: 10.2147/TCRM.S117321. eCollection 2017. Ther Clin Risk Manag. 2017. PMID: 28721057 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grant support
- R01AG 023178/AG/NIA NIH HHS/United States
- P30DK034987/DK/NIDDK NIH HHS/United States
- T32KD07634/PHS HHS/United States
- 5R01CA124402/CA/NCI NIH HHS/United States
- P50 AG005134/AG/NIA NIH HHS/United States
- R01CA44684/CA/NCI NIH HHS/United States
- R01 CA124402/CA/NCI NIH HHS/United States
- T32 MH017119/MH/NIMH NIH HHS/United States
- R01 AG 023178/AG/NIA NIH HHS/United States
- R01 ES017876/ES/NIEHS NIH HHS/United States
- U01CA 93326/CA/NCI NIH HHS/United States
- R01DK094738/DK/NIDDK NIH HHS/United States
- R01CA136887/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
